Pocket Naloxone Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $6.47M
Latest Deal Amount
  • Investors
  • 10

Pocket Naloxone General Information

Description

Operator of a pharmaceutical company intended to explore new therapeutic products for opioid overdoses management. The company offers over-the-counter Naloxone Hydrochloride product, enabling individuals and clinicians with a life-saving antidote that reverses opioid overdoses and prevents avoidable deaths.

Contact Information

Website
www.pocketnaloxone.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 4701 Sangamore Road
  • Suite 100 North
  • Bethesda, MD 20816
  • United States
+1 (301) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pocket Naloxone Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 02-Sep-2021 $6.47M 00.000 Completed Generating Revenue
To view Pocket Naloxone’s complete valuation and funding history, request access »

Pocket Naloxone Patents

  • 4

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Pocket Naloxone Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3134943-A1 Devices and methods for delivering pharmaceutical compositions Pending 26-Mar-2019 000000000
US-20200306514-A1 Devices and methods for delivery of pharmaceutical compositions Pending 26-Mar-2019 0000000000
US-11191934-B2 Devices and methods for delivery of pharmaceutical compositions Active 26-Mar-2019 A61M31/00 00

Pocket Naloxone Executive Team (5)

Name Title Board Seat Contact Info
Ashanthi Mathai Co-Founder, Chief Executive Officer & Board Member
Sonnie Kim Ph.D Chief Operating Officer
Behshad Sheldon Board Member & Co-Founder
Kathryn Bowsher Co-Founder & Board Member
Farzad Soleimani MD Chief Medical Officer
To view Pocket Naloxone’s complete executive team members history, request access »

Pocket Naloxone Board Members (4)

Name Representing Role Since
Andrea Barthwell MD Self Board Member 000 0000
Ashanthi Mathai Pocket Naloxone Co-Founder, Chief Executive Officer & Board Member 000 0000
Behshad Sheldon Pocket Naloxone Board Member & Co-Founder 000 0000
Kathryn Bowsher Self Co-Founder & Board Member 000 0000
To view Pocket Naloxone’s complete board members history, request access »

Pocket Naloxone Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pocket Naloxone Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advisors.Fund Venture Capital Minority 000 0000 000000 0
Alumni Ventures Venture Capital Minority 000 0000 000000 0
Catalytic Impact Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Houston Angel Network Angel Group Minority 000 0000 000000 0
ImpactAssets Impact Investing Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial